Dr. Craig Shimasaki is a scientist, businessperson, and serial entrepreneur with a passion for translating scientific and medical discoveries into acutely needed products so that more patients can live longer, healthier lives. He co-founded multiple companies and participated in taking several public in the U.S. and Canadian stock exchanges. His experience is in translating basic research discoveries into business enterprises in the therapeutic, diagnostic, and medical device areas. He is the founder of BioSource Consulting Group and the co-founder and CEO of Moleculera Biosciences, a neuroimmunology precision medicine company focused on identifying the underlying roots of neurologic, psychiatric, and behavioral disorders triggered by an autoimmune response. He has spent over 35 years working in the fields of molecular biology, viral pathogenesis, and infection-triggered neuropsychiatric disorders. He started his career at Genentech and has experience across all stages of research, development, clinical trials, and regulatory approval of technology from bench to bedside. His scientific background includes epitope mapping of HIV proteins, genetic-based predictors of breast cancer risk, influenza and RSV diagnostics and therapeutics, and the pathogenesis of infection-triggered neuropsychiatric disorders. He has led multiple products through the FDA approval process and is a co-inventor on multiple patents. He received his BS in Biochemistry from the University of California at Davis, his PhD in Molecular Biology and Biotechnology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business. He teaches entrepreneurship as an Adjunct Professor and Senior Entrepreneur-in-Residence at the University of Oklahoma, Price School of Business. Dr. Shimasaki is a mentor to first-time biotech CEOs at the Termeer Foundation in Boston. Internationally, he teaches and mentors scientists, physicians, and biotech leaders on how to translate their discoveries into acutely needed medical interventions. Dr. Shimasaki has authored and edited three books, “The Business of Bioscience: What Goes Into Making a Biotechnology Product”, “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies”, and the 2nd edition of “Biotechnology Entrepreneurship: Leading, Managing and Commercializing Innovative Products.”